Summary
- Profile Type
- Business Offer
- POD Reference
- BOUA20251128001
- Term of Validity
- 12 December 2025 - 12 December 2026
- Company's Country
- Ukraine
- Type of partnership
- Commercial agreement
- Supplier agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The company is applying from Ukraine. It is proposed to supply climate equipment and ventilation systems for commercial facilities, domestic premises, as well as for public and private medical institutions. It is planned to conclude a partnership agreement for long-term cooperation and regular supplies.
- Full Description
- The proposal concerns the BioSTOP 730 ultraviolet air-disinfection module designed for integration into ventilation systems and ducted air conditioners. The device provides high-efficiency air sterilization in residential, commercial, industrial, and medical facilities, including public and private healthcare institutions. BioSTOP 730 offers a technological solution aimed at significantly reducing airborne infection risks. The module uses six amalgam UVC lamps with a peak wavelength of 254 nm, proven to deactivate the DNA and RNA of viruses, bacteria, and fungi. Under typical indoor conditions, the module reduces the probability of infection by a factor of 9–22, delivering a hygiene level comparable to medical-grade standards. One of the key innovations is the staggered lamp layout, minimizing shadow zones and ensuring uniform irradiation across the entire airflow cross-section. The maximum distance from the lamp to the air stream is only 81 mm, providing considerably higher irradiation intensity compared to single-row arrangements. Internal reflective aluminum foil enhances irradiation by redirecting UVC beams back into the air stream. The module includes a control panel with individual LED indicators for each lamp, enabling quick detection of lamp failure without disassembling the housing. This feature ensures continuous performance monitoring and operational safety. A built-in airflow turbulizer increases irradiation efficiency by improving air mixing. The module delivers an average dose of 0.345 mJ/cm² and a peak dose of 0.497 mJ/cm², outperforming many commercial alternatives. At repeated air passes, the system achieves >99.9% reduction of airborne pathogens, including viruses, bacteria, and fungal spores. BioSTOP 730 has a compact design — only 730 mm in length — allowing installation in limited-space ventilation ducts. It is compatible with rectangular air ducts 1156×197 mm and can be integrated into most ducted AC units or supply-exhaust ventilation systems with minimal adaptation. The device uses long-life amalgam lamps with an expected service life of 12,000 hours, which significantly reduces operating costs and maintenance frequency. The module complies with ISO 9001, CE, RoHS, and national sanitary standards, confirming its suitability for medical and public environments.Through its optimized optical geometry, high irradiation power, turbulence enhancement, individual lamp control, and universal duct compatibility, the BioSTOP 730 provides a reliable and effective air-disinfection solution. It is engineered for long-term continuous operation and can be maintained without removing the module from the ventilation system. Overall, BioSTOP 730 is an innovative, high-performance UVC sterilization module that delivers medical-grade air safety within modern HVAC systems.
- Advantages and Innovations
-
The company offers a comprehensive set of technological, production, and organizational advantages that ensure a high level of reliability and innovation in its products. The team consists of qualified specialists with extensive experience in HVAC engineering, air-disinfection technologies, and industrial manufacturing processes. Their expertise enables the development of solutions that meet strict international standards of quality and safety. The technological base includes modern equipment for metal processing, UVC integration, electronic component assembly, and optical calibration, allowing the company to manufacture devices with high precision and stable performance. The company The use of long-life amalgam lamps and energy-efficient electronic ballasts further strengthens product durability and performance. Another advantage is the company’s capability to adapt its solutions to different HVAC systems, ensuring compatibility with a wide range of ducted air conditioners, ventilation units, and filtration systems. This flexibility allows integration into various types of facilities, including commercial, industrial, and medical environments.
Overall, the combination of certified production, advanced engineering expertise, and innovative product design provides a strong competitive foundation and ensures that the company delivers high-quality, reliable, and technologically advanced air-disinfection solutions. - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
The company is seeking partnerships primarily within the medical sector, including public and private healthcare institutions, as well as commercial organizations and facilities with high human occupancy such as educational institutions, public buildings, transport hubs, business centers, fitness clubs, and other locations where safe air quality is critical.Public medical institutions (hospitals, clinics, laboratories). Private medical centers and diagnostic facilities.
Commercial organizations responsible for facility management and air-quality safety. Large public venues (schools, universities, sports facilities, administrative buildings). Companies or institutions interested in implementing advanced air-disinfection technologies.
Expected role of the partner, to implement and operate the BioSTOP 730 air-disinfection module within their ventilation or air-conditioning systems. To provide technical access for installation and integration into existing HVAC infrastructure. To participate in monitoring and evaluating the performance of the installed systems. To collaborate in improving air-safety standards in high-density environments. To support the dissemination of innovative air-sterilization technologies in their sector.For medical institutions, to ensure proper compliance with health, safety, and certification requirements during deployment.
The company expects partners to demonstrate interest in adopting reliable and scientifically proven air-disinfection technologies that enhance safety and reduce the risk of airborne infections in high-occupancy environments. - Type and Size of Partner
- Big company
- SME <=10
- Type of partnership
- Commercial agreement
- Supplier agreement
Dissemination
- Market keywords
- 08004001 - Air filters and air purification and monitoring equipment
- Targeted countries
- Afghanistan
- Aland Islands
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bonaire, Saint Eustatius and Saba
- Bosnia and Herzegovina
- Botswana
- Bouvet Island
- Brazil
- British Indian Ocean Territory
- British Virgin Islands
- Brunei
- Bulgaria
- Burkina Faso
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Cayman Islands
- Central African Republic
- Chad
- Chile
- China
- Christmas Island
- Cocos Islands
- Colombia
- Comoros
- Cook Islands
- Costa Rica
- Croatia
- Cuba
- Curacao
- Cyprus
- Czechia
- Democratic Republic of the Congo
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Eswatini
- Ethiopia
- Falkland Islands
- Faroe Islands
- Fiji
- Finland
- France
- French Guiana
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard Island and McDonald Islands
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macao
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- Nicaragua
- Niger
- Nigeria
- Niue
- Norfolk Island
- North Korea
- North Macedonia
- Northern Mariana Islands
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territory
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Republic of the Congo
- Reunion
- Romania
- Russia
- Rwanda
- Saint Barthelemy
- Saint Helena
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Sint Maarten
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Georgia and the South Sandwich Islands
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor Leste
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Turks and Caicos Islands
- Tuvalu
- U.S. Virgin Islands
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- United States Minor Outlying Islands
- Uruguay
- Uzbekistan
- Vanuatu
- Vatican
- Venezuela
- Vietnam
- Wallis and Futuna
- Western Sahara
- Yemen
- Zambia
- Zimbabwe